Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.
about
Bioactivation of dapsone to a cytotoxic metabolite: in vitro use of a novel two compartment system which contains human tissues.Carbamazepine-hypersensitivity: assessment of clinical and in vitro chemical cross-reactivity with phenytoin and oxcarbazepine.Dapsone hydroxylamine induces premature removal of human erythrocytes by membrane reorganization and antibody bindingIdiosyncratic drug reactions: a mechanistic evaluation of risk factorsDrug bioactivation, covalent binding to target proteins and toxicity relevance.Adverse drug effects: Part II.Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance.Studies on the toxicity of analogues of dapsone in-vitro using rat, human and heterologously expressed metabolizing systems.N-Hydroxylation of dapsone by multiple enzymes of cytochrome P450: implications for inhibition of haemotoxicity.The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.The use of a three compartment in vitro model to investigate the role of hepatic drug metabolism in drug-induced blood dyscrasias.An investigation of the role of metabolism in dapsone-induced methaemoglobinaemia using a two compartment in vitro test system.Direct and metabolism-dependent toxicity of sulphasalazine and its principal metabolites towards human erythrocytes and leucocytes.Metabolism of ciamexon by human liver microsomes: an investigation into the formation of stable, chemically reactive and cytotoxic metabolites.Gonadal influence on the metabolism and haematological toxicity of dapsone in the rat.Mechanistic study on aniline-induced erythrocyte toxicity.Dapsone-induced agranulocytosis-possible involvement of low-activity N-acetyltransferase 2.
P2860
Q34357243-7D806294-91A7-4FE6-94BD-698AB391BC27Q34358782-7BC03A22-B579-4D0E-97DE-89ADB3BE8517Q34389048-7C4935F8-84C7-41A2-9419-D22E0BE27A6DQ34403403-2E2FCF94-114B-4A7B-AEE8-946FD66268AAQ36061821-731C1CFC-39D6-4D73-B2D4-83E7E69AAEC9Q36069466-DF24B209-B120-4BC1-AAB4-6962A7D47689Q40785532-D5EF06B8-95EC-4376-B12C-1827BC26DD97Q40927959-579DACEA-B907-421E-8E04-688553F6B69AQ42000770-6E974645-949F-4A7E-9AFF-8DA6CF462BDAQ42284991-CAE6BF04-EEF5-4B30-BA95-E4F4E3C275C6Q43201438-8608FAFE-7BA1-4162-830A-32F475F4F5E7Q43204778-31128C6D-356E-439E-A388-E0121C978E27Q43205035-78F7E768-D104-4AA1-85C4-68E6A3EF6F16Q43222882-EF224BE0-1791-4D04-B07C-06F24F18DD03Q44531314-0C4F112A-62C9-4652-8F4F-9FFF37E3E1A3Q46968923-0373C7D7-3FE3-424A-AC55-1F678E5398F3Q48098830-D70D1D2B-1942-4CC3-8C91-E3631472CA92
P2860
Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.
description
1989 nî lūn-bûn
@nan
1989 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.
@ast
Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.
@en
Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.
@nl
type
label
Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.
@ast
Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.
@en
Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.
@nl
prefLabel
Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.
@ast
Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.
@en
Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.
@nl
P2093
P2860
P1476
Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.
@en
P2093
Breckenridge AM
Coleman MD
P2860
P304
P356
10.1111/J.1365-2125.1989.TB03517.X
P407
P577
1989-10-01T00:00:00Z